nanofitins (Affilogic)

N/A

Report date: 2025/03/20 14:56:43
NME

Base Information

Drug Namenanofitins (Affilogic)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitors
TargetsTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsArthritis, RheumatoidOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffilogic Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesAffilogic Laboratories
Inactive CompaniesN/A
Active IndicationsArthritis, RheumatoidOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A